Literature DB >> 33653700

Rapid High-Throughput Whole-Genome Sequencing of SARS-CoV-2 by Using One-Step Reverse Transcription-PCR Amplification with an Integrated Microfluidic System and Next-Generation Sequencing.

Tao Li1, Hye Kyung Chung1, Papa K Pireku1, Brett F Beitzel2, Mark A Sanborn1, Cynthia Y Tang3,4,5,6, Richard D Hammer7, Detlef Ritter7, Xiu-Feng Wan3,4,5,6,8, Irina Maljkovic Berry1, Jun Hang9.   

Abstract

The long-lasting global COVID-19 pandemic demands timely genomic investigation of SARS-CoV-2 viruses. Here, we report a simple and efficient workflow for whole-genome sequencing utilizing one-step reverse transcription-PCR (RT-PCR) amplification on a microfluidic platform, followed by MiSeq amplicon sequencing. The method uses Fluidigm integrated fluidic circuit (IFC) and instruments to amplify 48 samples with 39 pairs of primers, including 35 custom-designed primer pairs and four additional primer pairs from the ARTIC network protocol v3. Application of this method on RNA samples from both viral isolates and clinical specimens demonstrates robustness and efficiency in obtaining the full genome sequence of SARS-CoV-2. This is a work of the U.S. Government and is not subject to copyright protection in the United States. Foreign copyrights may apply.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; acute respiratory illness; emerging infectious viral disease; genomes; next-generation sequencing; pandemic

Year:  2021        PMID: 33653700     DOI: 10.1128/JCM.02784-20

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

1.  Genomic surveillance of SARS-CoV-2 in US military compounds in Afghanistan reveals multiple introductions and outbreaks of Alpha and Delta variants.

Authors:  Irina Maljkovic Berry; Jun Hang; Christian Fung; Yu Yang; Marcus Chibucos; Adam Pollio; Jay Gandhi; Tao Li; Matthew A Conte; Grace M Lidl; Jay A Johannigman; Heather Friberg
Journal:  BMC Genomics       Date:  2022-07-15       Impact factor: 4.547

Review 2.  Strategies for Scaling up SARS-CoV-2 Molecular Testing Capacity.

Authors:  Sanchita Das; Karen M Frank
Journal:  Clin Lab Med       Date:  2022-03-08       Impact factor: 2.172

Review 3.  Microfluidics Technology in SARS-CoV-2 Diagnosis and Beyond: A Systematic Review.

Authors:  Mohd Raeed Jamiruddin; Bushra Ayat Meghla; Dewan Zubaer Islam; Taslima Akter Tisha; Shahad Saif Khandker; Mohib Ullah Khondoker; Md Ahsanul Haq; Nihad Adnan; Mainul Haque
Journal:  Life (Basel)       Date:  2022-04-27

4.  Development and validation of a high throughput SARS-CoV-2 whole genome sequencing workflow in a clinical laboratory.

Authors:  Sun Hee Rosenthal; Anna Gerasimova; Rolando Ruiz-Vega; Kayla Livingston; Ron M Kagan; Yan Liu; Ben Anderson; Renius Owen; Laurence Bernstein; Alla Smolgovsky; Dong Xu; Rebecca Chen; Andrew Grupe; Pranoot Tanpaiboon; Felicitas Lacbawan
Journal:  Sci Rep       Date:  2022-02-08       Impact factor: 4.379

Review 5.  Microfluidics-Based POCT for SARS-CoV-2 Diagnostics.

Authors:  Binfeng Yin; Xinhua Wan; A S M Muhtasim Fuad Sohan; Xiaodong Lin
Journal:  Micromachines (Basel)       Date:  2022-08-01       Impact factor: 3.523

6.  Intrahost SARS-CoV-2 k-mer identification method (iSKIM) for rapid detection of mutations of concern reveals emergence of global mutation patterns.

Authors:  Ashley Thommana; Migun Shakya; Jaykumar Gandhi; Christian K Fung; Patrick S G Chain; Irina Maljkovic Berry; Matthew A Conte
Journal:  bioRxiv       Date:  2022-08-16

7.  High-precision and cost-efficient sequencing for real-time COVID-19 surveillance.

Authors:  Sung Yong Park; Gina Faraci; Pamela M Ward; Jane F Emerson; Ha Youn Lee
Journal:  Sci Rep       Date:  2021-07-01       Impact factor: 4.379

Review 8.  Microfluidics-Based Biosensing Platforms: Emerging Frontiers in Point-of-Care Testing SARS-CoV-2 and Seroprevalence.

Authors:  Elda A Flores-Contreras; Reyna Berenice González-González; Iram P Rodríguez-Sánchez; Juan F Yee-de León; Hafiz M N Iqbal; Everardo González-González
Journal:  Biosensors (Basel)       Date:  2022-03-17

9.  Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days.

Authors:  Cynthia Y Tang; Yang Wang; Jane A McElroy; Tao Li; Richard Hammer; Detlef Ritter; Grace M Lidl; Richard Webby; Jun Hang; Xiu-Feng Wan
Journal:  J Med Virol       Date:  2021-07-05       Impact factor: 2.327

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.